Free Trial
→ The Dirty Secret About Gold Mining Stocks... (From Golden Portfolio) (Ad) Buy VRTX Stock  Free VRTX Stock Alerts

Vertex Pharmaceuticals (VRTX) SEC Filings & 10K Form

Vertex Pharmaceuticals logo
$511.74 +8.54 (+1.70%)
Closing price 04:00 PM Eastern
Extended Trading
$513.11 +1.37 (+0.27%)
As of 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Vertex Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
03/13/2025
10:10 AM		ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/12/2025
3:11 PM		Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
12:58 PM		Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/10/2025
12:02 PM		Vertex Pharmaceuticals (Subject)
WAGNER CHARLES F JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/10/2025
11:42 AM		ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2025
3:08 PM		Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:08 PM		ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
12:39 PM		Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
3:17 PM		ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
3:43 PM		Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
3:46 PM		Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
3:48 PM		Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
3:31 PM		Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
3:36 PM		Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
10:20 AM		ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
9:18 AM		Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
9:14 AM		Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2025
3:06 PM		Ambrose Kristen (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
3:07 PM		Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
3:09 PM		Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
3:11 PM		Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
10:38 AM		Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/25/2025
9:59 AM		Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/25/2025
10:13 AM		ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
3:07 PM		ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
2:45 PM		ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/19/2025
3:30 PM		Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:31 PM		Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:33 PM		LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:21 PM		Ambrose Kristen (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
10:29 AM		Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/18/2025
10:34 AM		Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
3:17 PM		LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
4:14 PM		Vertex Pharmaceuticals (Filer)
Form S-3ASR
02/13/2025
3:53 PM		Capital World Investors (Filed by)
Vertex Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/12/2025
3:46 PM		Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
3:48 PM		Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
3:50 PM		Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
3:52 PM		Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
3:26 PM		Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
3:21 PM		ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Urgent Bitcoin alert for RIGHT NOW (Ad)

Former billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 40-year career. During the presentation, Larry reveals a strategy every trader and investor needs to understand. He calls it “Bitcoin Skimming.”

So please… click here to watch now.
02/12/2025
3:24 PM		Ambrose Kristen (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
8:34 AM		FMR LLC (Filed by)
Vertex Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/11/2025
10:57 AM		Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/11/2025
10:05 AM		Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/11/2025
8:49 AM		Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/06/2025
3:43 PM		Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:45 PM		Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:37 PM		Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:38 PM		LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:32 PM		Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:35 PM		Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:07 PM		ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
2:51 PM		Vertex Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
9:31 AM		ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2024
3:15 PM		Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
1:58 PM		Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2024
3:11 PM		Vertex Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/17/2024
3:12 PM		SACHS BRUCE I (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
3:12 PM		Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
9:04 AM		Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2024
3:47 PM		Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2024
3:23 PM		LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2024
3:08 PM		Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
10:47 AM		Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
8:52 AM		Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2024
3:17 PM		Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
2:34 PM		SACHS BRUCE I (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/30/2024
2:25 PM		Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/25/2024
3:06 PM		Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2024
3:05 PM		Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2024
11:27 AM		Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/22/2024
12:16 PM		Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2024
9:27 AM		Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2024
9:23 AM		Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2024
3:09 PM		Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:11 PM		Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
8:54 AM		Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/12/2024
8:56 AM		Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2024
3:11 PM		Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:09 PM		Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
12:56 PM		Vertex Pharmaceuticals (Subject)
WAGNER CHARLES F JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
12:38 PM		Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/31/2024
9:50 AM		Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/30/2024
10:48 AM		Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/29/2024
3:08 PM		Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
9:05 AM		Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/28/2024
9:51 AM		Vertex Pharmaceuticals (Subject)
WAGNER CHARLES F JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/24/2024
12:13 PM		Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/22/2024
3:21 PM		Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
12:45 PM		SACHS BRUCE I (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Trump’s Great Society (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
05/20/2024
2:32 PM		Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2024
7:36 AM		Vertex Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2024
7:25 AM		ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
Form SC TO-T/A
05/15/2024
11:20 AM		Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2024
10:41 AM		ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2024
10:50 AM		Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/10/2024
7:01 AM		ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
Form SC TO-T/A
05/08/2024
7:54 AM		ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
Form SC TO-T/A
05/03/2024
3:05 PM		Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:VRTX) was last updated on 3/24/2025 by MarketBeat.com Staff
From Our Partners
Most gold “analysts” aren’t really gold analysts… [watch out]
People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...
Golden Portfolio | Sponsored
A market crash is coming—here’s when
The stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...
Chaikin Analytics | Sponsored
Your Wealth is Under Attack
Please don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...
American Alternative | Sponsored
Musk’s real agenda in D.C.
Companies connected to Elon’s new map of America are making major climbs in price. And on May 30, the next wav...
Porter & Company | Sponsored
Crypto’s crashing…but we’re still profiting
Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....
Crypto Swap Profits | Sponsored
Ex CIA predicts 40% “double crash” – April 11
The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...
Paradigm Press | Sponsored
Alert: DOGE goes live
Elon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...
Altimetry | Sponsored
A brutally honest economic warning for 2025 (see proof)
New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...
Banyan Hill Publishing | Sponsored